These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17623744)

  • 1. Feasibility of nationwide birth registry control selection in the United States.
    Spector LG; Ross JA; Puumala SE; Roesler M; Olshan AF; Bunin GR
    Am J Epidemiol; 2007 Oct; 166(7):852-6. PubMed ID: 17623744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Birth characteristics and hepatoblastoma risk in young children.
    Reynolds P; Urayama KY; Von Behren J; Feusner J
    Cancer; 2004 Mar; 100(5):1070-6. PubMed ID: 14983504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control selection and participation in an ongoing, population-based, case-control study of birth defects: the National Birth Defects Prevention Study.
    Cogswell ME; Bitsko RH; Anderka M; Caton AR; Feldkamp ML; Hockett Sherlock SM; Meyer RE; Ramadhani T; Robbins JM; Shaw GM; Mathews TJ; Royle M; Reefhuis J;
    Am J Epidemiol; 2009 Oct; 170(8):975-85. PubMed ID: 19736223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal and infant birth characteristics and hepatoblastoma.
    McLaughlin CC; Baptiste MS; Schymura MJ; Nasca PC; Zdeb MS
    Am J Epidemiol; 2006 May; 163(9):818-28. PubMed ID: 16510543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between perinatal and maternal characteristics and hepatoblastoma: a report from the UKCCS.
    Ansell P; Mitchell CD; Roman E; Simpson J; Birch JM; Eden TO
    Eur J Cancer; 2005 Mar; 41(5):741-8. PubMed ID: 15763651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The municipal register as a source of controls].
    Mur Pastor P; Infante-Rivard C; Peris Bonet R; Alvarez-Dardet Diaz C
    Rev Sanid Hig Publica (Madr); 1990; 64(11-12):589-97. PubMed ID: 2131586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using birth defects registry data to evaluate infant and childhood mortality associated with birth defects: an alternative to traditional mortality assessment using underlying cause of death statistics.
    Copeland GE; Kirby RS
    Birth Defects Res A Clin Mol Teratol; 2007 Nov; 79(11):792-7. PubMed ID: 17990340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal and neonatal hepatic tumors.
    Isaacs H
    J Pediatr Surg; 2007 Nov; 42(11):1797-803. PubMed ID: 18022426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatoblastoma and low birth weight: a trend or chance observation?
    Feusner J; Plaschkes J
    Med Pediatr Oncol; 2002 Nov; 39(5):508-9. PubMed ID: 12228908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of racial differences in childhood cancer risk in case-control studies and population-based cancer registries.
    Slusky DA; Mezei G; Metayer C; Selvin S; Von Behren J; Buffler PA
    Cancer Epidemiol; 2012 Feb; 36(1):36-44. PubMed ID: 22018954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creating a nationally representative sample of patients from trauma centers.
    Goble S; Neal M; Clark DE; Nathens AB; Annest JL; Faul M; Sattin RW; Li L; Levy PS; Mann NC; Guice K; Cassidy LD; Fildes JJ
    J Trauma; 2009 Sep; 67(3):637-42; discussion 642-4. PubMed ID: 19741413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatoblastoma in the Nordic countries.
    de Fine Licht S; Schmidt LS; Rod NH; Schmiegelow K; Lähteenmäki PM; Kogner P; Träger C; Stokland T; Schüz J
    Int J Cancer; 2012 Aug; 131(4):E555-61. PubMed ID: 22095187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case-control study of birth characteristics and the risk of hepatoblastoma.
    Heck JE; Meyers TJ; Lombardi C; Park AS; Cockburn M; Reynolds P; Ritz B
    Cancer Epidemiol; 2013 Aug; 37(4):390-5. PubMed ID: 23558166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 1 diabetes risk analysis on dried blood spot samples from population-based newborns: design and feasibility of an unselected case-control study.
    Eising S; Svensson J; Skogstrand K; Nilsson A; Lynch K; Andersen PS; Lernmark A; Hougaard DM; Pociot F; Nørgaard-Pedersen B; Nerup J
    Paediatr Perinat Epidemiol; 2007 Nov; 21(6):507-17. PubMed ID: 17937736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of controls in case-control studies on maternal medication use and risk of birth defects.
    Bakker MK; de Walle HE; Dequito A; van den Berg PB; de Jong-van den Berg LT
    Birth Defects Res A Clin Mol Teratol; 2007 Sep; 79(9):652-6. PubMed ID: 17668455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of childhood leukemia associated with vaccination, infection, and medication use in childhood: the Cross-Canada Childhood Leukemia Study.
    MacArthur AC; McBride ML; Spinelli JJ; Tamaro S; Gallagher RP; Theriault GP
    Am J Epidemiol; 2008 Mar; 167(5):598-606. PubMed ID: 18079130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatoblastoma incidence in the United States from 1973 to 1992.
    Ross JA; Gurney JG
    Med Pediatr Oncol; 1998 Mar; 30(3):141-2. PubMed ID: 9434819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Down syndrome among children and adolescents in 10 regions of the United States.
    Shin M; Besser LM; Kucik JE; Lu C; Siffel C; Correa A;
    Pediatrics; 2009 Dec; 124(6):1565-71. PubMed ID: 19948627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Birth Defects Cluster Study: a national approach to birth defects cluster investigations.
    Kucik JE; Bitsko RH; Williams L; Lazarus C; Jarman DW; Correa A
    Birth Defects Res A Clin Mol Teratol; 2008 Nov; 82(11):805-11. PubMed ID: 18985695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of cesarean section on neonatal mortality rates among very preterm infants in the United States, 2000-2003.
    Malloy MH
    Pediatrics; 2008 Aug; 122(2):285-92. PubMed ID: 18676545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.